Research Interests
Open to PhD applications in the field of preclinical oral dose development including targeted
- Drug delivery
- Amorphous solid dispersions
- Hot-Melt Extrusion
- 3D printing
- Continuous processing and PAT.
Current Research Opportunities
- Development of antifungal nanotherapeutics containing AmB+ drug combinations using an advanced continuous manufacturing technology
- Development of paediatric-centred anti-malaria nanotherapeutic formulations using an advanced continuous manufacturing technology
- Development of Innovative Diabetic Foot Ulcer Treatment Strategies using Photodynamic Therapy + Combination Delivery Systems
- Developing magneto-electric nanoparticles for advanced drug delivery of therapeutic agents for the treatment of neurological tuberculosis and HIV
- Development of Solid-state Therapeutic Protein Formulations for Oral Delivery via Advanced and Continuous Manufacturing Technologies
- Development of Variable Dose Combination Products Using FDM 3D Printing
- The Development of Innovative Indwelling Medical Devices containing Biosensor Technology
Public outreach & key achievements
Research students
Name: Zian Zhang
PhD title: Manufacture of Multi-Drug Formulations using Melt Extrusion and FDM-3D printing Technologies
Years of Study: 2
Country: China
Name: Dijia Liu
PhD title: Development of Patient-Centric Formulation Strategies using Hot Melt Extrusion
Years of Study: 1
Country: China
Name: Jacob Yang
PhD title: Manufacture of Amorphous Solid Dispsersions using HME
Years of Study: 3
Country: China
Name: Daniel Sedough-Abbasian
PhD title: Development of lipid-based nanocarriers using melt extrusion for oral peptide delivery
Years of Study: 1
Country: UK
Alumni: Where are they now
Name: Zhai Hui
PhD title: Using Fluidised Bed Hot Melt Granualtion as a Novel Pharmaceutical Technology to Manufacture Solid Oral Dosage Forms
Years of Study: 3
Country: China
Current position: R&D Director Beijing Pharma
Name: Colette Lagan
PhD title: Continuous Manufacturing for Production of Drug Enabled Formulations of Poorly Water-soluble Drugs
Years of Study: 4 – including industrial placement
Country: UK
Current position: Process Development Engineer Amgen
Name: Dan Margetson
PhD Title:
Years of Study: 7 Years – Part-Time through GSK
Country: UK
Current Position: Director – Manfacturing Science and Technology, Theramex